Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters. Am J Physiol Renal Physiol 305: F1491-F1497, 2013. First published September 4, 2013; doi:10.1152/ajprenal.00004.2013.-Thiazolidinediones (TZDs), which are synthetic peroxisome proliferator-activated receptor subtype-gamma (PPAR gamma), agonists are highly effective for treatment of type 2 diabetes. However, the side effect of fluid retention has significantly limited their application. Most of the previous studies addressing TZD-induced fluid retention employed healthy animals. The underlying mechanism of this phenomenon is still incompletely understood, particularly in the setting of disease state. Th...
Much concern has arisen regarding critical adverse effects of thiazolidinediones (TZDs), including r...
Synthetic agonists of the peroxisomal proliferator-activated re-ceptor subtype (PPAR-) are highly b...
Alteration in renin‐angiotensin system (RAS) has been implicated in the pathophysiology of diabetic ...
Aquaporin 2 (AQP2) is the vasopressin-regulated water channel palying a crucial role in urine concen...
Thiazolidinediones cause sodium retention and edema by a direct effect on the kidneys. The aim of th...
BACKGROUND/AIMS: Thiazolidinediones (TZDs, like rosiglitazone (RGZ)) are peroxisome proliferator-act...
Background/aimsThiazolidinediones (TZDs, like rosiglitazone (RGZ)) are peroxisome proliferator-activ...
Thiazolidinediones are activators of the nuclear receptor PPARγ with proven efficacy on glucose home...
Background—The side effects of fluid retention and edema of the thiazolidinedione (TZD) class of per...
Background/Aims: Thiazolidinediones are highly beneficial in the treatment of type II diabetes. Howe...
Background: Rosiglitazone (Ros) has been shown to attenuate CXCL8 and ICAM-1 overexpression in renal...
Background/Aims: Thiazolidinediones are highly beneficial in the treatment of type II diabetes. Howe...
Zhou L, Panasiuk A, Downton M, Zhao D, Yang B, Jia Z, Yang T. Systemic PPAR gamma deletion causes se...
Obesity-related albuminuria is associated with decline of kidney function and is considered a first ...
Obesity-related albuminuria is associated with decline of kidney function and is considered a first ...
Much concern has arisen regarding critical adverse effects of thiazolidinediones (TZDs), including r...
Synthetic agonists of the peroxisomal proliferator-activated re-ceptor subtype (PPAR-) are highly b...
Alteration in renin‐angiotensin system (RAS) has been implicated in the pathophysiology of diabetic ...
Aquaporin 2 (AQP2) is the vasopressin-regulated water channel palying a crucial role in urine concen...
Thiazolidinediones cause sodium retention and edema by a direct effect on the kidneys. The aim of th...
BACKGROUND/AIMS: Thiazolidinediones (TZDs, like rosiglitazone (RGZ)) are peroxisome proliferator-act...
Background/aimsThiazolidinediones (TZDs, like rosiglitazone (RGZ)) are peroxisome proliferator-activ...
Thiazolidinediones are activators of the nuclear receptor PPARγ with proven efficacy on glucose home...
Background—The side effects of fluid retention and edema of the thiazolidinedione (TZD) class of per...
Background/Aims: Thiazolidinediones are highly beneficial in the treatment of type II diabetes. Howe...
Background: Rosiglitazone (Ros) has been shown to attenuate CXCL8 and ICAM-1 overexpression in renal...
Background/Aims: Thiazolidinediones are highly beneficial in the treatment of type II diabetes. Howe...
Zhou L, Panasiuk A, Downton M, Zhao D, Yang B, Jia Z, Yang T. Systemic PPAR gamma deletion causes se...
Obesity-related albuminuria is associated with decline of kidney function and is considered a first ...
Obesity-related albuminuria is associated with decline of kidney function and is considered a first ...
Much concern has arisen regarding critical adverse effects of thiazolidinediones (TZDs), including r...
Synthetic agonists of the peroxisomal proliferator-activated re-ceptor subtype (PPAR-) are highly b...
Alteration in renin‐angiotensin system (RAS) has been implicated in the pathophysiology of diabetic ...